Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 6/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL29102608 | 0.91 | ALDH1A1 (0.53) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Bicarbonate SCHEMBL909943 | 0.87 | ALDH1A1 (0.78) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Carbamic Acid SCHEMBL28700287 | 0.85 | ALDH1A1 (0.75) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Acetic Acid SCHEMBL1878883 | 0.85 | ALDH1A1 (0.75) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Acrylic Acid SCHEMBL1741910 | 0.84 | TSHR (0.56) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Acrylic Acid SCHEMBL4448295 | 0.84 | TSHR (0.56) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Acrylic Acid SCHEMBL3835470 | 0.84 | ALDH1A1 (0.67) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Succinic Acid SCHEMBL5468972 | 0.81 | TDP1 (0.69) | ALDH1A1TDP1TSHRCA2MAPK1 | |
| Acrylic Acid Methyl Ester SCHEMBL15418484 | 0.81 | TSHR (0.57) | ALDH1A1TDP1TSHRCA2CYP3A4 | |
| Formic Acid SCHEMBL28548084 | 0.81 | ALDH1A1 (0.75) | ALDH1A1TDP1TSHRCA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100441179-C | Transdermal administration of (r)-3,3-diphenylpropylamine monoesters. | SANOL ARZNEI SCHWARZ GMBH (DE) | 2008-12-10 | — | — | CN | disclosed |
| CN-1767820-A | Transdermal administration of (r)-3,3-diphenylpropylamine monoesters. | SANOL ARZNEI SCHWARZ GMBH (DE) | 2006-05-03 | — | — | CN | disclosed |
| US-20050226919-A1 | Device for transdermal administration for the treatment of urinary tract disorders | UCB PHARMA GMBH (DE) | 2005-10-13 | — | — | US | disclosed |
| EP-1293198-B1 | Device for transdermal administration for the treatment of urinary tract disorders | SANOL ARZNEI SCHWARZ GMBH (DE) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003024432-A2 | DEVICE FOR TRANSDERMAL ADMINISTRATION FOR THE TREATMENT OF URINARY TRACT DISORDERS | SCHWARZ PHARMA AG (DE) | 2003-03-27 | — | — | WO | disclosed |
| EP-1293198-A1 | Device for transdermal administration for the treatment of urinary tract disorders | SCHWARZ PHARMA AG (DE) | 2003-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050226919-A1 | Device for transdermal administration for the treatment of urinary tract disorders | AR, CYP17A1, TACR1 | ALDH1A1 1928/4885TDP1 4163/4885TSHR 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.